Evaluate the Impact of the CDSSNCT00904072
Integrated Novel Clinical Decision Support System (CDSS) in a Computerized Physician Order Entry System
An observational study of Evaluate the Impact of the CDSS, run by National Taiwan University Hospital at 1 site in Taiwan.
Trial summary
The purpose of this study is to understand the impact of CDSS by knowing the prescribers actions to the CDSS, also the influence of prescribing error announced by pharmacists. Read more about this study
- Who is it for?
- Ages 1 day and older
- Conditions the study is for
- Evaluate the Impact of the CDSS
- How many people
- 50,000 participants
- Where
- 1 siteTaiwan
- Study dates
- Feb 2009to not given
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 day and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: The prescriptions which induced the alert windows pop out.
Who may be able to join
- The prescriptions which induced the alert windows pop out.
Who cannot join
- The prescriptions which not induced the alert windows pop out.
Trial locations and contacts
1 site in 1 country.
Taiwan1 site, 1 recruiting
- Recruiting
National Taiwan University Hospital Taipei, Taiwan
Taipei
Fe-Lin Lin Wu, 886-2-23123456 ext. 88389, flwu@ntu.edu.tw
Fe-Lin Lin Wu
About this study
Official title: Integrated a Novel Clinical Decision Support System (CDSS) in a Computerized Physician Order Entry System
The purpose of this study is to understand the impact of CDSS by knowing the prescribers actions to the CDSS, also the influence of prescribing error announced by pharmacists.
Read the detailed description
- To assess the sensitivity of the CDSS which could identify some specific prescribing errors (ex: duplication of drugs, dosage that exceed the maximum dose,prescribes drugs that have drug-drug interactions).
- To identify what kind of drugs are most likely to cause duplication use by the physicians, and what kind of drugs are most likely to exceed the maximum dosage, also to know what kind of drugs are most likely to cause drug-drug interaction that physicians encounter during prescribing.
- To evaluate the percentage of physician acceptance of the prescribing errors identify by the CDSS.
- What's the impact of CDSS on pharmacist announced prescribing error.
- Conditions
- Evaluate the Impact of the CDSS
- Keywords
- CDSS, prescribing error, prescribing errors influenced by CDSS, CPOE
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| accepted | The suggestions provided by the CDSS which were accepted by the physicians. | |
| denied | The suggestions provided by the CDSS which were denied by the physicians. |
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 May 2009 (estimated)
- Study startFeb 2009
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Evaluate the Impact of the CDSSStudies of the same condition, open and under way.
- More trials run by National Taiwan University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Retrospective
- Enrolment
- 50,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- National Taiwan University Hospital
- Sponsor type
- University, hospital or other
- Investigators
- Fe-Lin Lin Wu, Associate Professor, Principal investigator, National Taiwan University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00904072
- Sponsor's protocol ID
- 20080306OR
- Status last verified
- May 2009
- First submitted
- 17 May 2009
- Last updated
- 19 May 2009
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 May 2009. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Integrated a Novel Clinical Decision Support System (CDSS) in a Computerized Physician Order Entry System
- ClinicalTrials.gov ID
- NCT00904072
- Acronym / sponsor ID
- 20080306OR
- Conditions
- Evaluate the Impact of the CDSS
- Keywords
- CDSS, prescribing error, prescribing errors influenced by CDSS, CPOE
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 50,000 participants (estimated)
- Lead sponsor
- National Taiwan University HospitalUniversity, hospital or other
- Study start
- Feb 2009
- First posted
- 19 May 2009 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to understand the impact of CDSS by knowing the prescribers actions to the CDSS, also the influence of prescribing error announced by pharmacists.
Detailed description
- To assess the sensitivity of the CDSS which could identify some specific prescribing errors (ex: duplication of drugs, dosage that exceed the maximum dose,prescribes drugs that have drug-drug interactions).
- To identify what kind of drugs are most likely to cause duplication use by the physicians, and what kind of drugs are most likely to exceed the maximum dosage, also to know what kind of drugs are most likely to cause drug-drug interaction that physicians encounter during prescribing.
- To evaluate the percentage of physician acceptance of the prescribing errors identify by the CDSS.
- What's the impact of CDSS on pharmacist announced prescribing error.
Study design
- Observational model
- Case-control
- Time perspective
- Retrospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| accepted | – | –The suggestions provided by the CDSS which were accepted by the physicians. |
| denied | – | –The suggestions provided by the CDSS which were denied by the physicians. |
Who may qualify
- Ages
- 1 day and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- The prescriptions which induced the alert windows pop out.
Key inclusion criteria (1 listed)
- The prescriptions which induced the alert windows pop out.
Key exclusion criteria (1 listed)
- The prescriptions which not induced the alert windows pop out.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 May 2009.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Fe-Lin Lin Wu, Associate Professor principal investigator
National Taiwan University Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Evaluate the Impact of the CDSS, run by National Taiwan University Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 19 May 2009. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Fe-Lin Lin Wu, Associate Professor (886-2-23123456 ext. 88389, flwu@ntu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2009.